ANNA THYNE: Open Payments
NPI 1124580766 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 32 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $166 · 2025 $690
Food & beverage: $690
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $224 |
| AstraZeneca Pharmaceuticals LP | 10 | $175 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| ABBVIE INC. | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Exact Sciences Corporation | 1 | $21 |
| PFIZER INC. | 1 | $18 |
Products named: Ozempic, AIRSUPRA, REXULTI, CAPLYTA, Auvelity, FARXIGA, BREZTRI, JARDIANCE.
Industry payments across TX — which companies pay providers there.
